| Net Cash Provided by (Used in) Operating Activities |
$499,593 |
USD |
36% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$300,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,747 |
USD |
|
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
3,254,475,740 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
956,997,116 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$199,593 |
USD |
75% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$240,362 |
USD |
-79% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$11,327,652 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$11,327,652 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Depreciation |
$1,235 |
USD |
165% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$16,747 |
USD |
|
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$9,877,997 |
USD |
7% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
12,500,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$19,081,548 |
USD |
2.3% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
5,847,937 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$2,246,033 |
USD |
-0.34% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |